/Passle/5f3d6e345354880e28b1fb63/MediaLibrary/Images/2025-07-10-13-52-35-189-686fc5a39f23a993118ba1a0.png)
On 22 September 2026, clinicians, founders, investors and policymakers gathered at the Royal College of Obstetricians and Gynaecologists...
Our services
Sectors
Content hubs
The Safety Net
An overview of the OSA, covering its scope, key obligations and what organisations need to navigate the evolving regulatory landscape.
Read more about The Safety Net
The UK’s consumer law regime (DMCC)
Evolving consumer, advertising and competition requirements, and how organisations can prepare for increased enforcement and compliance demands.
Read more about The UK’s consumer law regime (DMCC)
Women's health and innovation
We advise companies in the women's health sector on the commercial, legal and regulatory challenges of bringing new therapies and solutions to market, helping to address the gender health gap.
Read more about Women's health and innovation
/Passle/5f3d6e345354880e28b1fb63/SearchServiceImages/2026-09-21-15-33-29-071-6ab14e49ba6cdd81f304d592.jpg)
Ben Lammin and Daniel Owen recently attended Cambridge Tech Week where Professor George Malliaras FRS used his keynote speech to...
The European Medicines Agency (EMA) has recently launched a “Women’s health” landing page on its website (here) to bring together...
/Passle/5f3d6e345354880e28b1fb63/MediaLibrary/Images/2026-09-11-10-59-38-715-6aa3df1a181cfb8b954e603a.png)
In our first episode of (Medical) Crimes and (Data) Misdemeanours, Marc Dautlich and Alex Denoon write to the European Commission’s AI...
/Passle/5f3d6e345354880e28b1fb63/SearchServiceImages/2026-08-10-14-02-25-111-6a79d9f1f45ff5f0bdb36e63.jpg)
This article was originally published by Kluwer Patent Blog. An important aspect of the English common law system is the ability of...
/Passle/5f3d6e345354880e28b1fb63/SearchServiceImages/2026-08-07-13-24-22-128-6a75dc86fd3ca7369989ee1b.jpg)
One Nucleus convened this year’s ON Helix event at the Babraham Research Campus in Cambridge, attended by Bristows’ Jamie May and Erik...
/Passle/5f3d6e345354880e28b1fb63/SearchServiceImages/2026-07-30-11-35-40-160-6a6b370c7f6e92629d6bd205.jpg)
On 2 August 2026, the EU AI Act reaches its general date of application - the point at which most of its provisions take effect and...
/Passle/5f3d6e345354880e28b1fb63/SearchServiceImages/2026-07-29-15-55-17-436-6a6a2265e230966fe56477eb.jpg)
The MHRA today released new guidance (AVT Guidance) on Ambient Voice Technology (AVT) products and the circumstances in which these do...
/Passle/5f3d6e345354880e28b1fb63/SearchServiceImages/2026-07-24-13-08-01-450-6a6363b1ac33e13032303392.jpg)
The global biotech market is moving along two conflicting paths. On the one hand, Western pharmaceutical companies are seeking new...
/Passle/5f3d6e345354880e28b1fb63/SearchServiceImages/2026-07-17-09-23-59-736-6a59f4af0200e5cf71ca3461.jpg)
On 26 June, the European Commission (EC) announced the opening of a competition law investigation into allegations of a campaign of...
/Passle/5f3d6e345354880e28b1fb63/SearchServiceImages/2026-07-02-14-31-25-706-6a46763df9386209bf867977.jpg)
We are proud to report our successful defence for SOPHiA GENETICS of a PI application brought by Guardant Health Inc in the UPC Court of...
/Passle/5f3d6e345354880e28b1fb63/SearchServiceImages/2026-06-25-15-49-07-814-6a3d4df359692c6f00bf7a7a.jpg)
On 19 June 2026, the Court of Appeal (CoA) issued its judgment in Pfizer/Flynn v CMA, drawing a line under the long-running UK phenytoin...